These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9104038)

  • 1. Effect of inclusion body contaminants on the oxidative renaturation of hen egg white lysozyme.
    Maachupalli-Reddy J; Kelley BD; De Bernardez Clark E
    Biotechnol Prog; 1997; 13(2):144-50. PubMed ID: 9104038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative renaturation of hen egg-white lysozyme. Folding vs aggregation.
    De Bernardez Clark E; Hevehan D; Szela S; Maachupalli-Reddy J
    Biotechnol Prog; 1998; 14(1):47-54. PubMed ID: 9496669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative renaturation of lysozyme at high concentrations.
    Hevehan DL; De Bernardez Clark E
    Biotechnol Bioeng; 1997 May; 54(3):221-30. PubMed ID: 18634088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renaturation of lysozyme--temperature dependence of renaturation rate, renaturation yield, and aggregation: identification of hydrophobic folding intermediates.
    Fischer B; Sumner I; Goodenough P
    Arch Biochem Biophys; 1993 Oct; 306(1):183-7. PubMed ID: 8215401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimized procedure for renaturation of recombinant human bone morphogenetic protein-2 at high protein concentration.
    Vallejo LF; Rinas U
    Biotechnol Bioeng; 2004 Mar; 85(6):601-9. PubMed ID: 14966801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refolding kinetics of denatured-reduced lysozyme in the presence of folding aids.
    Dong XY; Huang Y; Sun Y
    J Biotechnol; 2004 Oct; 114(1-2):135-42. PubMed ID: 15464607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cooperative effect of artificial chaperones and guanidinium chloride on lysozyme renaturation at high concentrations.
    Dong XY; Shi JH; Sun Y
    Biotechnol Prog; 2002; 18(3):663-5. PubMed ID: 12052090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the structure of the denatured state of lysozyme on the aggregation reaction at the early stages of folding from the reduced form.
    Ohkuri T; Shioi S; Imoto T; Ueda T
    J Mol Biol; 2005 Mar; 347(1):159-68. PubMed ID: 15733925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysozyme refolding at high concentration by dilution and size-exclusion chromatography.
    Goa YG; Guan YX; Yao SJ; Cho MG
    J Zhejiang Univ Sci; 2003; 4(2):136-41. PubMed ID: 12659225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein refolding assisted by periodic mesoporous organosilicas.
    Wang X; Lu D; Austin R; Agarwal A; Mueller LJ; Liu Z; Wu J; Feng P
    Langmuir; 2007 May; 23(10):5735-9. PubMed ID: 17402759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A kinetic study of the competition between renaturation and aggregation during the refolding of denatured-reduced egg white lysozyme.
    Goldberg ME; Rudolph R; Jaenicke R
    Biochemistry; 1991 Mar; 30(11):2790-7. PubMed ID: 2007117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renaturation of Escherichia coli-derived recombinant human macrophage colony-stimulating factor.
    Tran-Moseman A; Schauer N; De Bernardez Clark E
    Protein Expr Purif; 1999 Jun; 16(1):181-9. PubMed ID: 10336876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ethanol on folding of hen egg-white lysozyme under acidic condition.
    Sasahara K; Nitta K
    Proteins; 2006 Apr; 63(1):127-35. PubMed ID: 16411236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical assessment of the impact of mixing on dilution refolding.
    Mannall GJ; Titchener-Hooker NJ; Chase HA; Dalby PA
    Biotechnol Bioeng; 2006 Apr; 93(5):955-63. PubMed ID: 16353172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equilibrium and kinetic folding of hen egg-white lysozyme under acidic conditions.
    Sasahara K; Demura M; Nitta K
    Proteins; 2002 Dec; 49(4):472-82. PubMed ID: 12402357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refolding of therapeutic proteins produced in Escherichia coli as inclusion bodies.
    Misawa S; Kumagai I
    Biopolymers; 1999; 51(4):297-307. PubMed ID: 10618597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transition state in the folding-unfolding reaction of four species of three-disulfide variant of hen lysozyme: the role of each disulfide bridge.
    Yokota A; Izutani K; Takai M; Kubo Y; Noda Y; Koumoto Y; Tachibana H; Segawa S
    J Mol Biol; 2000 Feb; 295(5):1275-88. PubMed ID: 10653703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial chaperone-assisted refolding in a microchannel.
    Yamamoto E; Yamaguchi S; Sasaki N; Kim HB; Kitamori T; Nagamune T
    Bioprocess Biosyst Eng; 2010 Jan; 33(1):171-7. PubMed ID: 19727834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein activity in bacterial inclusion bodies correlates with predicted aggregation rates.
    de Groot NS; Ventura S
    J Biotechnol; 2006 Aug; 125(1):110-3. PubMed ID: 16621081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovery and reuse of the molecular chaperone GroEL for in vitro protein refolding.
    Guise AD; Chaudhuri JB
    Biotechnol Prog; 1998; 14(2):343-6. PubMed ID: 9548790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.